342 related articles for article (PubMed ID: 31735133)
1. Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma.
Bas O; Ozbek A; Guven D; Aktepe O; Kılıc L; Kertmen N; Erman M
J Oncol Pharm Pract; 2020 Jul; 26(5):1230-1233. PubMed ID: 31735133
[TBL] [Abstract][Full Text] [Related]
2. Nivolumab induced remitting seronegative symmetrical synovitis with pitting edema in a patient with melanoma: a case report.
Ngo L; Miller E; Valen P; Gertner E
J Med Case Rep; 2018 Feb; 12(1):48. PubMed ID: 29478412
[TBL] [Abstract][Full Text] [Related]
3. Remitting seronegative symmetrical synovitis with pitting edema syndrome complicated with primary lung cancer.
Matsuoka H; Matsubara H; Sugimura A; Uchida T; Ichihara T; Miyauchi Y; Kondo T; Nakajima H
Int Cancer Conf J; 2017 Jan; 6(1):16-21. PubMed ID: 31149462
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome mimicking symptoms of polymyalgia rheumatica: a case report.
Tarasiuk-Stanislawek K; Dumusc A; Favrat B; Kokkinakis I
J Med Case Rep; 2022 Aug; 16(1):334. PubMed ID: 36028914
[TBL] [Abstract][Full Text] [Related]
5. Remitting seronegative symmetrical synovitis with pitting edema syndrome in maintenance hemodialysis.
Matsugasumi T; Nakanouchi T; Mikami K; Shiraishi T; Kadoya M; Toriyama S; Taniguchi H; Fujihara A; Hongo F; Ukimura O
IJU Case Rep; 2020 Nov; 3(6):278-281. PubMed ID: 33163925
[TBL] [Abstract][Full Text] [Related]
6. Remitting seronegative symmetrical synovitis with pitting edema: a case report.
Tanaka Y; Kohchi K; Kitamoto K
J Med Case Rep; 2022 Mar; 16(1):125. PubMed ID: 35331322
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy.
Yamamoto S; Fujita S; Mukai T; Sawachika H; Morita Y
Intern Med; 2020 Feb; 59(4):599. PubMed ID: 31666472
[No Abstract] [Full Text] [Related]
8. Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Should Be Treated with Low-dose Prednisolone During Pembrolizumab Therapy.
Yamamoto S; Fujita S; Mukai T; Sawachika H; Morita Y
Intern Med; 2020 Feb; 59(4):597-598. PubMed ID: 31666471
[No Abstract] [Full Text] [Related]
9. Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome associated with bilateral pleural and pericardial effusions: a case report.
Yanamoto S; Fukae J; Fukiyama Y; Fujioka S; Ouma S; Tsuboi Y
J Med Case Rep; 2016 Jul; 10():198. PubMed ID: 27439425
[TBL] [Abstract][Full Text] [Related]
10. Pazopanib- and bevacizumab-induced reversible heart failure in a patient with metastatic renal cell carcinoma: A case report.
Abdallah AO; Vallurupalli S; Kunthur A
J Oncol Pharm Pract; 2016 Jun; 22(3):561-5. PubMed ID: 25956420
[No Abstract] [Full Text] [Related]
11. Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome with Pembrolizumab for Lung Squamous Cell Carcinoma: A Case Report.
Yoshida M; Hara S; Nishioka R; Kobayashi T; Murase Y; Kimura H; Mizushima I; Kawano M
Intern Med; 2023 Dec; ():. PubMed ID: 38072406
[TBL] [Abstract][Full Text] [Related]
12. Synchronous Occurrence of Bazex Syndrome and Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome in a Patient with Lung Cancer.
Aoshima Y; Karayama M; Sagisaka S; Yasui H; Hozumi H; Suzuki Y; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Suda T
Intern Med; 2019 Nov; 58(22):3267-3271. PubMed ID: 31292397
[TBL] [Abstract][Full Text] [Related]
13. Remitting seronegative symmetrical synovitis with pitting edema syndrome induced by pembrolizumab in patient with urothelial carcinoma.
Yoshimura A; Yamanaka K; Tadokoro R; Wakita T; Fukae S; Yoshida T; Sekiguchi M; Kishikawa H
IJU Case Rep; 2022 Jul; 5(4):219-222. PubMed ID: 35795121
[TBL] [Abstract][Full Text] [Related]
14. An unusual case of remitting seronegative symmetrical synovitis with pitting edema: Case report and literature review.
Joseph AD; Kumanan T; Aravinthan N; Suganthan N
SAGE Open Med Case Rep; 2020; 8():2050313X20910920. PubMed ID: 32215210
[TBL] [Abstract][Full Text] [Related]
15. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab.
Gauci ML; Baroudjian B; Laly P; Madelaine I; Da Meda L; Vercellino L; Bagot M; Lioté F; Pages C; Lebbé C
Semin Arthritis Rheum; 2017 Oct; 47(2):281-287. PubMed ID: 28438383
[TBL] [Abstract][Full Text] [Related]
16. Vanishing bile duct syndrome associated with pazopanib after progression on pembrolizumab.
Zhong YY; McLean L; Buckle A; Siva S; Tran B
Can J Urol; 2020 Aug; 27(4):10339-10341. PubMed ID: 32861263
[TBL] [Abstract][Full Text] [Related]
17. Remitting seronegative symmetrical synovitis with pitting edema syndrome postsecond COVID-19 vaccination: a case report.
Hodifa Y; Khalayli N; Hodaifa A; Kudsi M
Ann Med Surg (Lond); 2023 Aug; 85(8):4118-4120. PubMed ID: 37554915
[TBL] [Abstract][Full Text] [Related]
18. Successful re-administration of Pazopanib in a patient with metastatic renal cell carcinoma and a history of Pazopanib-induced nephrotic syndrome: a case report.
Jeon SY; Lee NR; Yim CY
BMC Nephrol; 2019 Jan; 20(1):1. PubMed ID: 30606155
[TBL] [Abstract][Full Text] [Related]
19. Remitting seronegative symmetrical synovitis with pitting edema (RS3PE syndrome).
Hung SC; Kung YY; Lin HY
J Formos Med Assoc; 1999 Jul; 98(7):516-8. PubMed ID: 10463003
[TBL] [Abstract][Full Text] [Related]
20. Pegilodecakin as monotherapy or in combination with anti-PD-1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A, G, H and I of IVY Phase I study.
Tannir NM; Papadopoulos KP; Wong DJ; Aljumaily R; Hung A; Afable M; Kim JS; Ferry D; Drakaki A; Bendell J; Naing A
Int J Cancer; 2021 Jul; 149(2):403-408. PubMed ID: 33709428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
